News / Health

Measles Virus Proves Deadly Against Cancer

Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.
Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.

Related Articles

Video Could Existing Drugs Be Used to Treat Deadly MERS Virus?

In lab studies, drugs against cancer, neurological disorders and other ailments show promise to help treat respiratory ailment

New Treatment Regenerates Muscle Lost in Traumatic Injury

Researchers say implanting material from a pig's bladder at the wound site enticed the patient's own stem cells to become muscle cells and regenerate tissue that had been lost
A new study has, for the first time, demonstrated that a specific kind of virotherapy can infect and kill cancer in humans, leaving healthy cells unharmed.
 
The study, conducted by the Mayo Clinic in Minnesota, involved just two patients, both of whom received a “single intravenous dose of an engineered measles virus (MV-NIS) that is selectively toxic to myeloma plasma cells," researchers said.
 
Multiple myeloma affects the plasma cells in the bone marrow and causes skeletal or soft tissue tumors. It is rarely cured.
 
The therapy brought about a complete remission in one of the patients, while only improving the second patient.
 
“This is the first study to establish the feasibility of systemic oncolytic virotherapy for disseminated cancer,” said Dr. Stephen Russell, a Mayo Clinic hematologist, and first author of the paper and co-developer of the therapy in a statement. “These patients were not responsive to other therapies and had experienced several recurrences of their disease.”
 
In an interview with VOA, Russell called viruses “the last untapped bioresource as destructive bioagents against cancer.”
 
The two patients in the trial were given enough measles virus to vaccinate 100 million people. In a video about the treatment, Mayo doctors say the modified measles virus makes cancer cells join together and “essentially explode.”
 
The therapy also may boost the patient’s immune system, allowing it to “mop up” any remaining cancer, they said.
 
Using re-engineered viruses to fight cancer, also known as oncolytic virotherapy, is nothing new, dating back to the 1950s, according to the Mayo Clinic. But, according to researches, this study provides the “first well documented case of a patient with disseminated cancer having a complete remission at all disease sites after virus administration.”
 
Good results with this kind of therapy have been seen with rodents, but this is the first time success has been reported in a human being. However, remission was only achieved in one of the two patients.

Mixed results for patients
 
The other patient did not respond as well. Nonetheless, by using a sophisticated imaging technique, doctors were able to tell that the virus had targeted cancerous cells.
 
Russell said he and his colleagues found the difference in reaction between the two patients “puzzling,” but had some theories about why.
 
He said the patient who’d gone into remission had less myeloma in her body and that the second patient’s cancer was in a “very advanced state” with “massive tumors in the legs and abdomen.”
 
Another theory was that the second patient had more tumors in the muscles.
 
“If we’d treated her earlier, we’d have done better, Russell said, adding that they might also have seen better results at a higher dose.
 
There were negative side effects, he said, such as severe flu-like symptoms almost immediately upon dosing. Despite that, one patient called the side effects “trivial,” compared to other treatments they’d received, according to Russell.
 
William Phelps, Director of the Preclinical and Translational Cancer Research Program at the American Cancer Society, said the study is exciting because it shows efficacy with humans.
 
“Viruses are very good at disseminating throughout the body,” he said, adding that they’re also adept at hunting, detecting and infecting metastatic tumors.
 
Another advantage of using viruses is that they’re mutable, said Phelps.
 
“We can make a lot of changes to change what cells they infect,” he said. “We can change their payloads to specifically kill cancer.”
 
According to an editorial accompanying the paper, Dr. John C. Bell of the Centre for Innovative Cancer Research in Ottawa, Canada, described the findings as a “benchmark to strive for and improve upon.”
 
When asked if the study had implications for other types of cancer, Russell answered with an emphatic yes.
 
“There’s no real reason why it can’t work on other cancers,” said Bell, adding that cancer provides the “perfect substrate” for viruses because they’re metabolically active, fast growing and, “don’t know how to turn off.
 
“Once the virus gets in there, it can just move,” he said. “There are a lot of reasons they’re happier growing in cancer.”
 
More trials are planned.
 
“We want to take this virus and test it much more efficiently in a larger group to determine how often it works,” said Russell.
 
According to the Mayo Clinic, more of the MV-NIS therapy is being manufactured for a larger, phase 2 clinical trial later this year.
 
Phelps said his one concern about the study was that the two patients did not have any antibodies for measles, making them very rare because most people have been vaccinated against or had the measles.
 
One possible next step is “trying to engineer the virus so that it wouldn’t be neutralized by your antibodies," said Phelps. “Intuitively, you should be able to do that."
 
Russell believes that what this study has proved is valuable and can be built upon.
 
“We recently have begun to think about the idea of a single shot cure for cancer, and that’s our goal with this therapy,” he said.

The findings appear in the peer-reviewed journal Mayo Clinic Proceedings.

Here's a video about the treatment:
 

You May Like

Nigeria Incumbent in Tight Spot as Poll Nears

Muhammadu Buhari is running a strong challenge to Goodluck Jonathan, amid a faltering economy and Boko Haram security worries More

Video Liberia's Almost Last Ebola Patient Grateful but Still Grieving

Beatrice Yardolo tells VOA that despite her fame, life is still a struggle as she waits for government's promise of support to arrive More

Video Cambodian Land Grabs Threaten Traditional Communities

At least seven different indigenous groups in Ratanakiri depend mainly on forest products for their survival, say they face loss of their land, traditional way of life More

This forum has been closed.
Comment Sorting
Comments
     
by: MOD from: china
May 18, 2014 8:21 AM
Hope it's useful and THX~!

by: Dr. Livkin from: UK
May 17, 2014 9:01 PM
However, there is POISON in the flu vaccine=MERCURY, a deadly neurotoxin that is NOT to be introduced into the human body unless of course, you want to invite cognitive disorders and cancer. FACTS AND RESEARCH WILL DICTATE THAT.

by: kanapathy pillai yogaraaj from: srilanka
May 17, 2014 5:05 AM
we support civilrights-Like

by: jom from: china
May 16, 2014 3:31 PM
Thank you for this hopeful article

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Liberia's Almost Last Ebola Patient Grateful but Still Grievingi
X
Benno Muchler
March 26, 2015 3:41 PM
Beatrice Yardolo was to make history as Liberia’s last Ebola patient. Liberians recently started counting down 42 days, the period that has to go by without a single new infection until the World Health Organization can declare a country Ebola-free. That countdown stopped on March 20 when there was another new case of Ebola, making Yardolo’s story a reminder that Ebola is far from over. Benno Muchler reports from Monrovia.
Video

Video Liberia's Almost Last Ebola Patient Grateful but Still Grieving

Beatrice Yardolo was to make history as Liberia’s last Ebola patient. Liberians recently started counting down 42 days, the period that has to go by without a single new infection until the World Health Organization can declare a country Ebola-free. That countdown stopped on March 20 when there was another new case of Ebola, making Yardolo’s story a reminder that Ebola is far from over. Benno Muchler reports from Monrovia.
Video

Video Cambodian Land Grabs Threaten Traditional Communities

Indigenous communities in Cambodia's Ratanakiri province say the government’s economic land concession policy is taking away their land and traditional way of life, making many fear that their identity will soon be lost. Local authorities, though, have denied this is the case. VOA's Say Mony went to investigate and filed this report, narrated by Colin Lovett.
Video

Video US, South Korea Conduct Joint Military Exercises

The Eighth U.S. Army Division and the Eighth Republic of Korea Mechanized Infantry Division put on a well orchestrated show of force for the media this week during their joint military training exercises in South Korea. VOA’s Seoul correspondent Brian Padden was there and reports the soldiers were well disciplined both in conducting a complex live fire exercise and in staying on message with the press.
Video

Video Space Program Status Disappoints 'Last Man on the Moon'

One of the films that drew big crowds last week at the annual South by Southwest festival in Austin, Texas, tells the story of the last human being to stand on the moon, U.S. astronaut Eugene Cernan. It has been 42 years since Cernan returned from the moon and he laments that no one else has gone there since. VOA’s Greg Flakus reports.
Video

Video Young Filmmakers Shine Spotlight on Giving Back

A group of student filmmakers from across the United States joined President Barack Obama at the White House this month for the second annual White House Student Film Festival. Fifteen short films were officially selected from more than 1,500 entries by students aged 6 through 18. The filmmakers and their families then joined the president and a group of celebrities for a screening of their films. VOA’s Julie Taboh reports.
Video

Video VOA Exclusive: Interview with Afghan President Ashraf Ghani

Afghan President Ashraf Ghani, during his first visit as president to Washington, gave a one-on-one interview with VOA Afghan Service reporter Said Suleiman Ashna, about his request for a change in U.S. troop levels, the threat from the Islamic State, and repairing relations with the United States and Pakistan. The interview was held at Blair House, late Sunday, in Pashto.
Video

Video California Science Center Tells Story of Dead Sea Scrolls

The ancient manuscripts were uncovered in the mid-20th century, and they are still yielding clues about life and religious beliefs in ancient Israel. As VOA's Mike O'Sullivan reports, an exhibit in Los Angeles shows how modern science is bringing the history of these ancient documents to life.
Video

Video Angelina Jolie Takes Another Bold Step

Hollywood actress and filmmaker Angelina Jolie has revealed she had her ovaries and fallopian tubes removed to lower her odds of getting cancer. Doctors say the huge publicity over her decision will help raise awareness about the importance of cancer screening. VOA’s George Putic has more

All About America

Circumventing Censorship

An Internet Primer for Healthy Web Habits

As surveillance and censoring technologies advance, so, too, do new tools for your computer or mobile device that help protect your privacy and break through Internet censorship.
More